InvestorsHub Logo
Followers 423
Posts 39062
Boards Moderated 1
Alias Born 12/21/2006

Re: None

Monday, 01/27/2020 12:05:45 PM

Monday, January 27, 2020 12:05:45 PM

Post# of 52124
2 separate responses regarding the GCAN/Symotax JV inquiries yesterday. They are very telling that the OralTab is coming to market and no one can stop it! Revenues follow for sure.


The Symtomax / GCAN JV is 100% we have spent a lot of money and time putting together PR, and for this up coming launch of the Oral Tab product which as I've mentioned is going to be a huge success.




This was from the reply to WW email sent yesterday inquiring on GCAN being mentioned in the article in question and the validity of the GCAN/JV joint venture:

HERE IS THE REPLY FROM SYMTOMAX PEOPLE!

Dear XXXX,

Thank you for taking the time to inform us of the link and the slanderous claims.

We had already been made aware of a blog site in which serious and false allegations have been made toward Symtomax. We are currently in contact with our legal representatives and are seeking legal advice as to the best course of action.

We can however, confirm that the Oral tabs is still scheduled to launch as planned and we share the excitement of this innovative product being readily available to the public.

Yours sincerely
Mark Gary


Praça Bom Sucesso, Edifício Península nº127/131. 8ºandar, Escritório 801, 4150-146 Porto, Portugal

phone: + 351 914 951 757
email: mark@symtomax.com
web: www.symtomax.com

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GCAN News